Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

JOURNAL ARTICLE published September 2015 in Cancer Science

Authors: Terufumi Kato | Hiroshige Yoshioka | Isamu Okamoto | Akira Yokoyama | Toyoaki Hida | Takashi Seto | Katsuyuki Kiura | Dan Massey | Yoko Seki | Nobuyuki Yamamoto